Cinctive Capital Management LP Elanco Animal Health Inc Transaction History

Cinctive Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.93 - $18.45 $366,759 - $523,334	28,365 Added 75.43%	65,967 $951,000
Q1 2024 May 15, 2024	SELL	$14.37 - $16.46 $752,959 - $862,471	-52,398 Reduced 58.22%	37,602 $612,000
Q4 2023 Feb 14, 2024	BUY	$8.6 - $14.94 $774,000 - $1.34 Million	90,000 New	90,000 $1.34 Million
Q3 2022 Nov 14, 2022	BUY	$12.41 - $32.42 $868,700 - $2.27 Million	70,000 New	70,000 $869,000
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $2.27 Million - $2.79 Million	-81,828 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $2.39 Million - $3 Million	81,828 New	81,828 $2.61 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.42B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.